Explore 3 Stock Ideas & Industry Insights Download Free Report

Guardian Pharmacy Services, Inc.

Company price
42.39 USD 2.52 ( 6.32%)
Last update at 2026-11-06T21:00:00Z
VOLUME
1085464
Market Cap
3040.43M
P/E
44.44

Momentum Score

…

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
40.22
Low
43.41
High
52 Week Price Range
23.14
Low
48.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
39.87
Dividend Yield
-
Revenue TTM
1463.41M
Revenue Per Share
23.22
Gross Profit TTM
316.58M
Debt / Equity
0.22
ROE
30.42%
Net Debt
-20.89M
ROCE
35.29%
Diluted EPS TTM
1.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 73.42M -66.48M 37.72M 49.66M 28.33M
Minority interest 0.26M -16.25M -13.82M -14.24M -12.01M
Net income 49.22M -87.29M 23.90M 35.42M 16.31M
Selling general administrative 220.02M 299.35M 167.36M 3.38M 13.03M
Selling and marketing expenses - 3.50M - 137.26M 118.09M
Gross profit 282.04M 244.37M 208.31M 185.87M 161.26M
Reconciled depreciation 22.34M 19.77M 18.23M 16.56M 16.53M
Ebit 88.91M -63.20M 40.58M 51.59M 29.96M
Ebitda 111.25M -43.43M 58.81M 68.15M 46.49M
Depreciation and amortization 22.34M 19.77M 18.23M 16.56M 16.53M
Operating income 88.91M -62.92M 40.95M 51.99M 30.15M
Other operating expenses 1359.77M 1291.33M 1005.25M 856.92M 761.92M
Interest expense 0.67M 3.28M 2.86M 1.93M 1.64M
Tax provision 24.46M 4.56M 0.00M - -
Net interest income -0.67M -3.28M -2.86M -1.93M -1.64M
Income tax expense 24.46M 4.56M - - -
Total revenue 1448.68M 1228.41M 1046.19M 908.91M 792.07M
Total operating expenses 193.13M 307.29M 167.36M 133.88M 131.12M
Cost of revenue 1166.64M 984.04M 837.88M 723.04M 630.81M
Total other income expense net -15.49M -3.56M -3.23M -2.33M -1.82M
Net income from continuing ops 48.96M -71.03M 37.72M 49.66M 28.33M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 412.66M 320.81M 271.17M 256.11M 235.85M
Intangible assets 18.48M 14.91M 11.98M 14.44M 17.09M
Other current assets 11.04M 9.62M 14.86M 10.12M 8.52M
Total liab 194.73M 170.83M 211.31M 180.18M 182.53M
Total stockholder equity 205.76M 142.67M 28.21M 42.73M 23.93M
Other current liab 30.20M 31.08M 29.29M 17.56M 34.99M
Common stock 0.06M 0.06M 28.21M 42.73M 24.11M
Capital stock 0.06M 0.06M - - -
Retained earnings 66.34M 17.12M - - -
Good will 79.74M 69.30M 56.05M 56.05M 54.63M
Cash 65.62M 4.66M 0.75M 0.61M 15.01M
Total current liabilities 160.70M 144.12M 138.01M 112.00M 111.54M
Net debt -20.89M 32.67M 68.40M 62.38M 40.03M
Short term debt 14.30M 10.62M 23.12M 16.34M 11.93M
Short long term debt - - 12.98M 7.96M 3.71M
Short long term debt total 44.72M 37.33M 69.15M 62.98M 55.04M
Other stockholder equity 139.35M 125.48M - - -0.00M
Total current assets 221.63M 151.99M 129.60M 120.00M 111.87M
Net receivables 101.61M 97.15M 77.26M 67.83M 55.25M
Long term debt - - 18.99M 22.97M 26.99M
Inventory 43.36M 40.55M 36.73M 41.44M 33.09M
Accounts payable 116.21M 102.42M 85.60M 78.10M 64.62M
Accumulated other comprehensive income - 0.00M - - -0.18M
Non currrent assets other 0.44M 5.66M 0.36M 0.43M 0.53M
Non current assets total 191.02M 168.82M 141.56M 136.12M 123.98M
Capital lease obligations 37.14M 30.13M 29.03M 25.88M 19.73M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -30.41M -13.44M -17.90M -13.15M
Total cashflows from investing activities -32.26M -30.41M -13.44M -17.90M -13.15M
Net borrowings -4.98M -36.48M -2.89M -2.80M -6.10M
Total cash from financing activities -7.07M -23.64M -57.23M -45.03M -36.79M
Net income 49.22M -71.03M 37.72M 49.66M 28.33M
Change in cash 60.96M 3.91M 0.14M -14.40M 8.56M
Begin period cash flow 4.66M 0.75M 0.61M 15.01M 6.45M
End period cash flow 65.62M 4.66M 0.75M 0.61M 15.01M
Total cash from operating activities 100.29M 57.96M 70.82M 48.52M 58.50M
Issuance of capital stock 29.04M 119.78M 0.00M - -
Depreciation 22.34M 19.77M 18.23M 16.56M 16.53M
Other cashflows from investing activities -12.68M 0.67M 2.10M 0.87M 0.54M
Dividends paid 0.00M 35.75M 38.42M 30.80M 17.36M
Change to inventory -0.88M -1.15M 4.43M -8.12M -0.24M
Change to account receivables -8.55M -25.48M -14.30M -16.79M -7.71M
Sale purchase of stock -29.04M -55.18M 0.00M - -
Other cashflows from financing activities -0.50M -16.02M -15.92M -11.42M -13.34M
Capital expenditures 19.58M 16.37M 14.56M 16.77M 9.28M
Change in working capital 6.38M -29.41M 15.60M -18.72M -1.47M
Stock based compensation 13.85M 131.49M -6.09M -3.38M 13.03M
Other non cash items 5.43M 7.14M 5.35M 4.40M 2.08M
Free cash flow 80.71M 41.59M 56.26M 31.75M 49.22M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
GRDN
Guardian Pharmacy Services, Inc.
2.52
6.32%
42.39 44.44 32.47 2.08 11.99 1.98 24.12
HCA
HCA Healthcare, Inc.
-12.49
2.46%
494.99 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
-3.13
1.09%
283.33 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
0.06
0.42%
14.62 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
-
-%
5.28 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

300 Galleria Parkway SE, Atlanta, GA, United States, 30339

404 810 0089

3600

Name Title Year Born
Mr. Fred P. Burke CEO, President & Director 1950
Mr. David K. Morris CFO, Executive VP & Director 1964
Mr. Kendall Forbes R.Ph. Executive Vice President of Sales & Operations 1957
Mr. David Martin Senior VP of Technology, Data & Senior Security Officer NA
Ms. Ashley Stockton Head of Investor Relations & Senior Director NA
Mr. Douglas Towns SVP of General Counsel & Senior Compliance Officer NA
Ms. Vicki Crabtree Vice President of Human Resources NA
Mr. Jeff Tuch CPA SVP of Purchasing & Pricing Analytics NA
Mr. Will Mudd CPA SVP of Finance NA
Bob Weir R.Ph SVP of Operations & Regulatory Support NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…